| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
24,270,000 |
| Market
Cap: |
653.35(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$15.28 - $30.85 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Fulgent Genetics is a holding company. Through its subsidiaries, Co. is a technology company providing COVID-19 testing services, molecular diagnostic testing services and genetic testing designed to provide physicians and patients with clinically actionable diagnostic information to improve the quality of patient care. Co. has developed a proprietary technology platform allowing Co. to provide a test menu. Combining next generation sequencing with its technology platform, Co. performs full-gene sequencing with deletion/duplication analysis in single-gene tests; pre-established, multi-gene, disease-specific panels; and customized panels that can be tailored to meet customer needs.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
100,000 |
100,000 |
| Total Buy Value |
$0 |
$0 |
$1,596,470 |
$1,596,470 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
15,572 |
21,149 |
25,950 |
41,286 |
| Total Sell Value |
$454,101 |
$575,129 |
$673,265 |
$994,236 |
| Total People Sold |
2 |
2 |
2 |
4 |
| Total Sell Transactions |
7 |
13 |
17 |
29 |
| End Date |
2025-09-14 |
2025-06-13 |
2024-12-13 |
2023-12-14 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
Gao Hanlin |
Chief Scientific Officer |
|
2025-12-02 |
4 |
S |
$28.33 |
$30,457 |
D/D |
(1,075) |
952,890 |
|
4% |
|
Xie Jian |
President and COO |
|
2025-12-02 |
4 |
S |
$28.33 |
$32,298 |
D/D |
(1,140) |
336,749 |
|
4% |
|
Kim Paul |
CFO and Treasurer |
|
2025-12-01 |
4 |
D |
$28.52 |
$32,256 |
D/D |
(1,131) |
331,150 |
|
- |
|
Xie Jian |
President and COO |
|
2025-11-28 |
4 |
S |
$29.57 |
$35,424 |
D/D |
(1,198) |
337,889 |
|
8% |
|
Gao Hanlin |
Chief Scientific Officer |
|
2025-11-28 |
4 |
S |
$29.57 |
$27,884 |
D/D |
(943) |
953,965 |
|
8% |
|
Kim Paul |
CFO and Treasurer |
|
2025-11-26 |
4 |
D |
$30.15 |
$35,155 |
D/D |
(1,166) |
332,281 |
|
- |
|
Hsieh Ming |
Chief Executive Officer |
|
2025-11-26 |
4 |
D |
$30.15 |
$88,762 |
D/D |
(2,944) |
799,221 |
|
- |
|
Xie Jian |
President and COO |
|
2025-11-24 |
4 |
S |
$30.47 |
$20,752 |
D/D |
(681) |
339,087 |
|
11% |
|
Gao Hanlin |
Chief Scientific Officer |
|
2025-11-24 |
4 |
S |
$30.47 |
$16,303 |
D/D |
(535) |
954,908 |
|
11% |
|
Hsieh Ming |
Chief Executive Officer |
|
2025-11-23 |
4 |
D |
$30.00 |
$63,480 |
D/D |
(2,116) |
802,165 |
|
- |
|
Kim Paul |
CFO and Treasurer |
|
2025-11-23 |
4 |
D |
$30.00 |
$20,130 |
D/D |
(671) |
333,447 |
|
- |
|
Xie Jian |
President and COO |
|
2025-11-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
339,768 |
|
- |
|
Xie Jian |
President and COO |
|
2025-11-19 |
4 |
S |
$29.10 |
$290,983 |
D/D |
(10,000) |
349,768 |
|
6% |
|
Kim Paul |
CFO and Treasurer |
|
2025-10-26 |
4 |
D |
$23.74 |
$65,119 |
D/D |
(2,743) |
334,118 |
|
- |
|
Gao Hanlin |
Chief Scientific Officer |
|
2025-10-26 |
4 |
D |
$23.74 |
$38,981 |
D/D |
(1,642) |
955,443 |
|
- |
|
Xie Jian |
President and COO |
|
2025-10-26 |
4 |
D |
$23.74 |
$103,340 |
D/D |
(4,353) |
359,768 |
|
- |
|
Gao Hanlin |
Chief Scientific Officer |
|
2025-09-03 |
4 |
S |
$22.03 |
$23,414 |
D/D |
(1,063) |
957,085 |
|
-23% |
|
Xie Jian |
President and COO |
|
2025-09-03 |
4 |
S |
$22.03 |
$24,846 |
D/D |
(1,128) |
364,121 |
|
-23% |
|
Kim Paul |
CFO and Treasurer |
|
2025-09-01 |
4 |
D |
$22.17 |
$25,074 |
D/D |
(1,131) |
336,861 |
|
- |
|
Xie Jian |
President and COO |
|
2025-08-27 |
4 |
S |
$21.48 |
$25,760 |
D/D |
(1,199) |
365,249 |
|
-25% |
|
Gao Hanlin |
Chief Scientific Officer |
|
2025-08-27 |
4 |
S |
$21.48 |
$20,260 |
D/D |
(943) |
958,148 |
|
-25% |
|
Hsieh Ming |
Chief Executive Officer |
|
2025-08-26 |
4 |
D |
$21.47 |
$63,208 |
D/D |
(2,944) |
804,281 |
|
- |
|
Kim Paul |
CFO and Treasurer |
|
2025-08-26 |
4 |
D |
$21.47 |
$25,034 |
D/D |
(1,166) |
337,992 |
|
- |
|
Gao Hanlin |
Chief Scientific Officer |
|
2025-08-25 |
4 |
S |
$21.50 |
$11,783 |
D/D |
(548) |
959,091 |
|
-26% |
|
Xie Jian |
President and COO |
|
2025-08-25 |
4 |
S |
$21.50 |
$14,965 |
D/D |
(696) |
366,448 |
|
-26% |
|
393 Records found
|
|
Page 1 of 16 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|